Ectoine enhances recombinant antibody production in Chinese hamster ovary cells by promoting cell cycle arrest

Publication date

2024-11-25

Authors

Jarusintanakorn, SalinthipISNI 0000000523880028
Mastrobattista, EnricoORCID 0000-0002-6745-2015ISNI 000000035187179X
Yamabhai, Montarop

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Chinese hamster ovary (CHO) cells represent the most preferential host cell system for therapeutic monoclonal antibody (mAb) production. Enhancing mAb production in CHO cells can be achieved by adding chemical compounds that regulate the cell cycle and cell survival pathways. This study investigated the impact of ectoine supplementation on mAb production in CHO cells. The results showed that adding ectoine at a concentration of 100 mM on the 3rd day of cultivation improved mAb production by improving cell viability and extending the culture duration. RNA sequencing analysis revealed differentially expressed genes associated with cell cycle regulation, cell proliferation, and cellular homeostasis, in particular promotion of cell cycle arrest, which was then confirmed by flow cytometry analysis. Ectoine-treated CHO cells exhibited an increase in the number of cells in the G0/G1 phase. In addition, the cell diameter was also increased. These findings support the hypothesis that ectoine enhances mAb production in CHO cells through mechanisms involving cell cycle arrest and cellular homeostasis. Overall, this study highlights the potential of ectoine as a promising supplementation strategy to enhance mAb production not only in CHO cells but also in other cell lines.

Keywords

Cell cycle arrest, Chinese hamster ovary (CHO), Differentially expressed gene (DEG), Ectoine, Monoclonal antibody, Production

Citation

Jarusintanakorn, S, Mastrobattista, E & Yamabhai, M 2024, 'Ectoine enhances recombinant antibody production in Chinese hamster ovary cells by promoting cell cycle arrest', New Biotechnology, vol. 83, pp. 56-65. https://doi.org/10.1016/j.nbt.2024.06.006